
|Articles|October 11, 2004
Panel urges adding warnings for child antidepressant use
A Food & Drug Administration advisory panel has recommended black-box alerts for commonly used antidepressants, warning that the drugs increase the risk of suicide when used in children and adolescents.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FDA-Approved Sunscreen Filter Bemotrizinol Debuts in New US Products
2
FDA Approves XFG-Targeted COVID-19 Vaccines From Multiple Companies
3
FDA Approves Stelara for Pediatric Ulcerative Colitis
4
COVID-19 in 2026: Why the Virus Still Threatens Vulnerable Patients
5




























